[Studies of the pathogenesis and therapy of meningococcal sepsis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D004438:Ecchymosis / Q000209:etiology; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007223:Infant; D008297:Male; D008589:Meningococcal Infections / Q000150:complications / Q000188:drug therapy; D018805:Sepsis / Q000209:etiology*; D013449:Sulfonamides / Q000627:therapeutic use; D014882:Water-Electrolyte Balance; D014884:Waterhouse-Friderichsen Syndrome / Q000150:complications
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D013449:Sulfonamides; D006493:Heparin; D005947:Glucose; D006854:Hydrocortisone
Rilievi in tema di patogenesi e terapia della sepsi meningococcica